Literature DB >> 16566668

Standardization of individualized treatments in a randomized controlled trial of acupuncture for stroke rehabilitation.

Rosa N Schnyer, Peter M Wayne, Ted J Kaptchuk, Xiaoming Cheng, Zhenzhen Zhang, William B Stason.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16566668     DOI: 10.1089/acm.2006.12.106

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


× No keyword cloud information.
  5 in total

1.  Reporting of Protocol Rationale and Content Validity in Randomized Clinical Trials of T'ai Chi: A Systematic Evaluation.

Authors:  Daniel Litrownik; Elizabeth Gilliam; Danielle Berkowitz; Gloria Y Yeh; Peter M Wayne
Journal:  J Altern Complement Med       Date:  2019-03-05       Impact factor: 2.579

2.  An innovative method to accommodate Chinese medicine pattern diagnosis within the framework of evidence-based medical research.

Authors:  Christine Berle; Deirdre Cobbin; Narelle Smith; Christopher Zaslawski
Journal:  Chin J Integr Med       Date:  2011-11-06       Impact factor: 1.978

3.  Development of protocols for randomized sham-controlled trials of complex treatment interventions: Japanese acupuncture for endometriosis-related pelvic pain.

Authors:  Rosa N Schnyer; Diane Iuliano; Joseph Kay; Monica Shields; Peter Wayne
Journal:  J Altern Complement Med       Date:  2008-06       Impact factor: 2.579

4.  Acupuncture Intervention Protocol: Consensus Process for a Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults: An NIH HEAL Initiative Funded Project.

Authors:  Arya Nielsen; Laura Ocker; Iman Majd; Jeff A Draisin; Katherine Taromina; Marjorie T Maggenti; Jaimie Long; Mark Nolting; Karen J Sherman
Journal:  Glob Adv Health Med       Date:  2021-05-26

5.  Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective.

Authors:  Christopher Zaslawski
Journal:  Evid Based Complement Alternat Med       Date:  2008-08-21       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.